Yonhap Infomax News5d ago
Drug developers Canaphtherapeutics and IM Biologics set to debut on KOSDAQ this week with IPO prices at top of indicative ranges following strong investor demand, while three companies open public subscriptions including precision cooling tech firm Licensemedical
#YonhapInfomax #Canaphtherapeutics #IMBiologics #KOSDAQListing #IPOSubscription #BookBuilding #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=109979
Canaphtherapeutics, IM Biologics to List on KOSDAQ This Week; Three IPO Subscriptions Open

Drug developers Canaphtherapeutics and IM Biologics set to debut on KOSDAQ this week with IPO prices at top of indicative ranges following strong investor demand, while three companies open public subscriptions including precision cooling tech firm Licensemedical

Yonhap Infomax
Yonhap Infomax NewsMar 1
K Bank and S Team set to debut on Korean exchanges this week following successful bookbuilding, while four biotech and fintech companies launch institutional and retail IPO processes with price ranges spanning 8,300-26,000 won amid strong investor demand
#YonhapInfomax #KBank #STeam #IPO #Bookbuilding #IMBiologics #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=107436
K Bank, S Team to List This Week as Four Companies Launch IPO Bookbuilding

K Bank and S Team set to debut on Korean exchanges this week following successful bookbuilding, while four biotech and fintech companies launch institutional and retail IPO processes with price ranges spanning 8,300-26,000 won amid strong investor demand

Yonhap Infomax